{"title":"Adaptive vs Conventional Deep Brain Stimulation of the Subthalamic Nucleus for Treatment of Parkinson's Disease: A Multicenter Retrospective Study.","authors":"Qinghua Li, Kailiang Wang, Jiping Li, Penghu Wei, Yongzhi Shan, Jianyu Li, Junming Zhu, Zhe Zheng, Chaoshi Niu, Chi Xiong, Weiguo Li, Qianqian Wu, Qihua Xiao, Guiyun Cui, Xiongfei Wang, Yuguang Guan, Guoming Luan, Baohui Liu, Huimin Dong, Siquan Liang, Haitao Li, Wenwen Xu, Guoguang Zhao, Yuqing Zhang","doi":"10.1016/j.neurom.2025.04.011","DOIUrl":"https://doi.org/10.1016/j.neurom.2025.04.011","url":null,"abstract":"<p><strong>Objectives: </strong>Conventional deep brain stimulation (cDBS) is an established treatment for Parkinson's disease (PD), whereas adaptive DBS (aDBS) represents a promising approach with potential advantages in minimizing stimulation-induced side effects and enhancing quality of life. This study evaluated the safety and efficacy of a newly developed aDBS closed-loop neurostimulation (CNS) device for one year across multiple centers, with the primary objective of comparing the outcomes of aDBS and cDBS.</p><p><strong>Materials and methods: </strong>This retrospective study included 62 patients with PD who underwent bilateral subthalamic nucleus (STN) DBS. Outcomes were assessed using the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Parkinson's Disease Questionnaire-39 (PDQ-39), and Schwab and England Activities Scale, whereas the levodopa-equivalent daily dose (LEDD) and adverse events were monitored. This two-phase trial randomized participants into Stim-on or Stim-off groups for 90-day postoperative comparison followed by nonrandomized evaluation of aDBS vs cDBS at 360 days after surgery.</p><p><strong>Results: </strong>At 90 days postoperatively, the Stim-on group exhibited superior outcomes to those in the Stim-off group except for LEDD and speech in the medication-on state. At the 360-day postoperative assessment, the aDBS group showed significantly greater improvements than did the cDBS group in MDS-UPDRS II (57.29% vs 33.02%, p = 0.022), MDS-UPDRS IV (59.83% vs 36.69%, p = 0.026), PDQ-39 (56.91% vs 27.37%, p = 0.031), and LEDD reduction (53.35% vs 29.16%, p = 0.002). CNS aDBS recorded clear STN-beta signals, which could be adopted as a biomarker.</p><p><strong>Conclusions: </strong>Both aDBS and cDBS significantly alleviate motor symptoms and enhance quality of life in patients with PD. Although comparable in motor symptom control, aDBS indicated advantages over cDBS across LEDD reduction, MDS-UPDRS II, MDS-UPDRS IV, and PDQ-39 over the long term. Further studies with extended follow-up and larger sample sizes are required to validate these results.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144248830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuromodulationPub Date : 2025-06-06DOI: 10.1016/j.neurom.2025.05.001
Kimberley Ladner, Eline M Versantvoort, Dave Mugan, Quoc C Vuong, Birte E Dietz, Annie Hu, Marjolein E G Thijssen, Robert B Gorman, Erika Petersen, Ilona Obara
{"title":"Preclinical Insights Into the Effects of Frequency and Pulse Width on Evoked Compound Action Potential Morphology During Spinal Cord Stimulation.","authors":"Kimberley Ladner, Eline M Versantvoort, Dave Mugan, Quoc C Vuong, Birte E Dietz, Annie Hu, Marjolein E G Thijssen, Robert B Gorman, Erika Petersen, Ilona Obara","doi":"10.1016/j.neurom.2025.05.001","DOIUrl":"10.1016/j.neurom.2025.05.001","url":null,"abstract":"<p><strong>Objectives: </strong>High-frequency spinal cord stimulation (SCS) at 1000 Hz was shown to reduce evoked compound action potential (ECAP) amplitude, likely owing to asynchronous firing of dorsal column (DC) axons. To investigate the relationship between SCS parameters and DC axon activation, we analyzed ECAP morphology across different stimulation frequencies and pulse widths (PWs).</p><p><strong>Materials and methods: </strong>Adult male Sprague-Dawley rats (200-400 g) were implanted with an epidural lead. To study SCS frequency effects, baseline recordings were taken at 2 Hz, followed by tests at 50, 200, 500, and 1000 Hz, with 2 Hz recovery periods; 200 Hz also was applied in a pig with an epidurally implanted lead. PW effects were assessed in rats by increasing the PW from 50 to 1000 μs, in 50 μs increments per minute.</p><p><strong>Results: </strong>In contrast to 50 Hz, SCS at 200, 500, and 1000 Hz reduced ECAP amplitude and increased peak latencies and ECAP width. Conduction velocity (CV) was reduced at 500 and 1000 Hz. Recovery intervals at 2 Hz, after 200, 500, and 1000 Hz, showed a gradual return to baseline values for ECAP morphology parameters. Similar effects occurred in the pig. Increasing PW prolonged peak latencies, with ECAP amplitudes decreasing from 200 to 250 μs.</p><p><strong>Conclusions: </strong>DC axon responses to SCS at increasing frequencies or PWs depend on their recovery state, as reflected in changes to ECAP morphology and CV. These effects may result from desynchronization, demyelination, or differences within fiber recruitment. Further investigation into these mechanisms can improve the efficacy of SCS therapy.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144234635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuromodulationPub Date : 2025-06-05DOI: 10.1016/j.neurom.2025.03.079
Furkan Gazozcu, Alessa Schütz, Ralph T Schär, Janine-Ai Schlaeppi
{"title":"The Impact of Spinal Cord Stimulation on Patients' Ability to Work and Work-Related Outcomes.","authors":"Furkan Gazozcu, Alessa Schütz, Ralph T Schär, Janine-Ai Schlaeppi","doi":"10.1016/j.neurom.2025.03.079","DOIUrl":"https://doi.org/10.1016/j.neurom.2025.03.079","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic low back pain is one of the most common causes of absence from work. This not only has economic consequences but also affects the mental health of patients. Furthermore, returning to work is one of the main concerns of patients with chronic pain. Spinal cord stimulation (SCS) has shown its effectiveness in pain reduction and quality of life in many studies. Work-related outcomes have often been neglected or only marginally documented.</p><p><strong>Objective: </strong>The aim of this study is to examine specific work-related data of the patients before and after surgery and to assess the influence of SCS on the ability to work with a review of the literature.</p><p><strong>Materials and methods: </strong>This is a single-center retrospective study with prospective data collection. All patients were operated on by the same surgeon at the University Hospital Bern between October 2018 and October 2022. Data were collected during postoperative follow-up and by telephone call. In addition, a literature search was conducted to identify previous research on this topic.</p><p><strong>Results: </strong>Of the 26 patients included in this study, 18 were on disability leave before SCS whereas eight were still working. After SCS, five of the 18 patients on disability leave were able to return to work within a mean period of 58.3 weeks with a standard deviation of 33.59 after surgery, with a workload of ≥20%. Two of these patients transitioned to a new profession. This corresponds to a return-to-work (RTW) rate of 27.8% for patients previously unemployed in our study. Among the eight patients who were employed before SCS, all were able to resume work. Those who had been working full-time (n = 4) maintained their full workload, whereas the four patients who had previously reduced their workload were able to sustain or even slightly increase their employment percentage.</p><p><strong>Conclusion: </strong>Our study shows a positive impact of SCS on the patients' work ability with an RTW rate of 27.8%. The findings not only indicate a favorable influence on patients' health and well-being but also create positive economic implications.</p>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144234636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuromodulationPub Date : 2025-06-01DOI: 10.1016/j.neurom.2025.03.072
Romina Sangiacomo MSc , Fermín Valera-Garrido PhD , Francisco Minaya-Muñoz PhD , Alberto Carcasona-Otal PT, MSc , Pablo Herrero PhD , Diego Lapuente-Hernández PT, MSc
{"title":"Effects of Ultrasound-Guided Percutaneous Neuromodulation on Shoulder Muscle Strength in CrossFit Athletes: A Pilot Randomized Controlled Trial","authors":"Romina Sangiacomo MSc , Fermín Valera-Garrido PhD , Francisco Minaya-Muñoz PhD , Alberto Carcasona-Otal PT, MSc , Pablo Herrero PhD , Diego Lapuente-Hernández PT, MSc","doi":"10.1016/j.neurom.2025.03.072","DOIUrl":"10.1016/j.neurom.2025.03.072","url":null,"abstract":"<div><h3>Background</h3><div>CrossFit integrates diverse functional movements to optimize overall fitness, with muscle strength training being a core component. Ultrasound-guided percutaneous neuromodulation (US-guided PNM) has emerged as a potential adjunct to enhance muscle strength gains; however, its efficacy in the upper limb in healthy individuals remains unexplored.</div></div><div><h3>Objective</h3><div>This study evaluated the efficacy of two US-guided PNM protocols (three sessions and one session) targeting the axillary and suprascapular nerves in improving shoulder muscle strength in healthy CrossFit athletes.</div></div><div><h3>Materials and Methods</h3><div>A pilot, randomized, controlled, single-blind clinical trial was conducted with 39 healthy CrossFit athletes randomly allocated to one of three groups: control (G1, no intervention), one session of US-guided PNM (G2), or three sessions of US-guided PNM (G3). Shoulder muscle strength was assessed using a hand-held dynamometer to measure external and internal rotation muscle strength at various shoulder positions before each treatment session (days 1, 7, and 14) and one week after the last session (day 21). Moreover, the one-repetition maximum (1RM) shoulder press exercise was evaluated on day 1 and day 21.</div></div><div><h3>Results</h3><div>No statistically significant differences were observed among groups for any outcome. However, the within-group analysis indicated statistically significant improvements over time in the treated limbs of intervention groups (G2 and G3), whereas no statistically significant changes were observed in the control (G1) or the untreated limbs of G2 and G3. The improvements were more consistent for shoulder strength measured in the neutral position than at 90° abduction.</div></div><div><h3>Conclusions</h3><div>Although US-guided PNM did not yield significantly greater improvements than did the control group, both one and three sessions targeting the axillary and suprascapular nerves enhanced rotational shoulder muscle strength in treated limbs and 1RM shoulder press performance. These findings should be interpreted with caution, and further investigation is warranted, particularly in populations with lower baseline strength and in exploring varied application parameters to optimize efficacy.</div></div><div><h3>Clinical Trial Registration</h3><div>The <span><span>Clinicaltrials.gov</span><svg><path></path></svg></span> registration number for the study is NCT06529770.</div></div>","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":"28 4","pages":"Pages 600-610"},"PeriodicalIF":3.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143780726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuromodulationPub Date : 2025-06-01DOI: 10.1016/j.neurom.2025.03.035
S. Thomson , N. Varela , V. Mehta , J. Calle , J. Vesper , S. Love-Jones , J. De Andres , S. Bayerl , B. Bujedo , G. Baranidharan , A. Mendiola , C. Perez , L. Demartini , J.W. Kallewaard , K. Gatzinsky , G. Matis , E. Goldberg
{"title":"33. Multidimensional outcomes of spinal cord simulation in patients with chronic pain: results from a European prospective multicenter observational study","authors":"S. Thomson , N. Varela , V. Mehta , J. Calle , J. Vesper , S. Love-Jones , J. De Andres , S. Bayerl , B. Bujedo , G. Baranidharan , A. Mendiola , C. Perez , L. Demartini , J.W. Kallewaard , K. Gatzinsky , G. Matis , E. Goldberg","doi":"10.1016/j.neurom.2025.03.035","DOIUrl":"10.1016/j.neurom.2025.03.035","url":null,"abstract":"","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":"28 4","pages":"Page S17"},"PeriodicalIF":3.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144189701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuromodulationPub Date : 2025-06-01DOI: 10.1016/j.neurom.2025.03.031
K. Waterhouse, A.M. Vitali, L. Gould, J. Norton, S. McLeod
{"title":"29. Initial experience with deep brain stimulation in a patient in minimally conscious state","authors":"K. Waterhouse, A.M. Vitali, L. Gould, J. Norton, S. McLeod","doi":"10.1016/j.neurom.2025.03.031","DOIUrl":"10.1016/j.neurom.2025.03.031","url":null,"abstract":"","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":"28 4","pages":"Page S15"},"PeriodicalIF":3.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144189629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuromodulationPub Date : 2025-06-01DOI: 10.1016/j.neurom.2025.03.053
H. Soar, P. Armstrong, P. Hall, A. Britten, H. Lambert, S. Atkin
{"title":"51. Restorative multifidus neurostimulation: a retrospective analysis of outcomes at 1 year at York hospital","authors":"H. Soar, P. Armstrong, P. Hall, A. Britten, H. Lambert, S. Atkin","doi":"10.1016/j.neurom.2025.03.053","DOIUrl":"10.1016/j.neurom.2025.03.053","url":null,"abstract":"","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":"28 4","pages":"Page S26"},"PeriodicalIF":3.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144189902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuromodulationPub Date : 2025-06-01DOI: 10.1016/j.neurom.2025.03.056
D. Anwar, S.C. Balasubramanian, G. Vajramani
{"title":"54. The successful use of narrow paddle electrodes for occipital nerve stimulation – a single centre study","authors":"D. Anwar, S.C. Balasubramanian, G. Vajramani","doi":"10.1016/j.neurom.2025.03.056","DOIUrl":"10.1016/j.neurom.2025.03.056","url":null,"abstract":"","PeriodicalId":19152,"journal":{"name":"Neuromodulation","volume":"28 4","pages":"Page S28"},"PeriodicalIF":3.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144189905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}